medscape.com
Negativewww.medscape.com ·
Sigmoidoscopy Cuts Colorectal Cancer Risk Men 2026a1000f7b
Public HealthWorldlanguages NorwegianMedicalHealth Technologies
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThis is a medical research article about the long-term efficacy of sigmoidoscopy screening for colorectal cancer. No direct commercial mechanism, company, commodity, or supply chain impact is identified. The study does not mention any product, service, investment, regulation, or price signal that would affect a specific sector or company. Therefore, no relevant sectors are selected.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Once-only sigmoidoscopy screening reduced CRC incidence by 28% and mortality by 37% in men over 23 years.
- Study involved 100,210 participants aged 50-64 in Norway.
- Cumulative CRC risk in men decreased from 6.0% to 4.3%.
- CRC death risk in men dropped from 2.2% to 1.4%.
- Published in Annals of Internal Medicine on May 12, 2026.